Peptides of 5 and 8 residues encoded by the leaders of attenuation regulated chloramphenicol-resistance genes inhibit the peptidyltransferase of microorganisms from the three kingdoms. Therefore, the ribosomal target for the peptides is likely to be a conserved structure and/or sequence. The inhibitor peptides "footprint" to nucleotides of domain V in large subunit rRNA when peptide-ribosome complexes are probed with dimethyl sulfate. Accordingly Inducible chloramphenicol (Cm)-resistance genes cat and cmlU are regulated by translation attenuation (1-4). In this form of translational control, the inducer Cm stalls a ribosome in a leader sequence located at the 5' end of the regulated transcripts. Stalling causes a localized change in the secondary structure of the mRNA and exposes a normally sequestered ribosome binding site, allowing translation of the resistance determinant (5, 6).
with nucleases that cleave at single-stranded (Ti endonuclease) and double-stranded (Vi endonuclease) sites. Both peptides selectively altered the susceptibility of domains IV and V of 23S rRNA to digestion by Ti endonuclease. Peptide effects on cleavage by Vi nuclease were observed only in domain V.
The Ti nuclease susceptibility of domain V of in vitrotranscribed 23S rRNA was also altered by the peptides, demonstrating that peptide binding to the rRNA is independent of ribosomal protein. We propose the peptides MVKTD and MSTSKNAD perturb peptidyltransferase center catalytic activities by altering the conformation of domains IV and V of 23S rRNA. These findings provide a general mechanism through which nascent peptides may cis-regulate the catalytic activities of translating ribosomes.
Inducible chloramphenicol (Cm)-resistance genes cat and cmlU are regulated by translation attenuation (1) (2) (3) (4) . In this form of translational control, the inducer Cm stalls a ribosome in a leader sequence located at the 5' end of the regulated transcripts. Stalling causes a localized change in the secondary structure of the mRNA and exposes a normally sequestered ribosome binding site, allowing translation of the resistance determinant (5, 6) .
Translation of the cat coding sequence results when a ribosome becomes stalled in the leader with its amino acyl site at leader codon 6 (7). This site of ribosome stalling is selected by the five codons that precede leader codon 6 (8) . These five codons specify a 5-mer peptide, MVKTD, that is an in vitro inhibitor of peptidyltransferase (PT; refs. 9 and 10) and translation termination (11) . PT inhibition in vitro requires relatively high peptide/ribosome ratios, and it has been suggested (9, 10) that inhibition in vivo depends on peptide synthesis at its target. The activation of translation of the cmLA resistance determinant also requires ribosome stalling, but at leader codon 9 (2). In the cmlU example, the eight codons upstream from the site of ribosome stalling specify an 8-mer peptide, MSTSKNAD, that inhibits PT (2) . Both the catencoded 5-mer peptide and the cmLA-encoded 8- Ti lane and the lanes containing RNA exposed to the 5-and 8-mers. Such changes presumably measure the direct or indirect effects of the inhibitor peptides on secondary structure of the rRNA (see text). The sequencing ladders (lanes A, C, G, and T) were generated by using RT. Therefore, the nucleotides shown in the sequencing ladder are the complements of the nucleotide in the rRNA; i.e., a C residue in the sequencing ladder is a G residue in the RNA. Parentheses indicate sites at which the designated change was observed only with particular rRNA preparations.
nuclease cleaves single-stranded RNA on the 3' side of guanosine residues (17) and Vi nuclease preferentially cleaves duplexed regions of RNA (18) . The susceptibility of sites within rRNA to these nucleases, therefore, provides an indication of secondary structure. Each site cleaved by the nucleases is a termination point for DNA synthesis by RT. Therefore, sites of nuclease-dependent termination of reverse transcription mark the locations of nuclease-susceptible sites. Additionally, RT has a probability of terminating at hairpin structures in uncleaved rRNA, which provides a further measure of secondary structure (19, 20 Biochemistry: Harrod and Lovett rRNA (Fig. 1) . Peptide effects on cleavage by Vi nuclease were limited to a single site, G2509, within domain V (Fig. 2) . Both peptides failed to alter the T1 nuclease susceptibility of domains I, II, III, and VI of 23S rRNA (data not shown). Additionally, the 3' one-third of 16S rRNA was examined and showed no peptide-induced changes in Ti nuclease susceptibility (data not shown). Fig. 3 summarizes peptide-induced changes in nuclease cleavages detected in 23S rRNA. Two of the changes, at G1989 and A2005, were observed only with particular batches of rRNA, and these are bracketed in Figs. 1 and 3. The variability of peptide effects on specific nucleotides, probably due to different levels of protein removal during phenol extraction, suggests that although the peptides bind to rRNA, their precise effects could be influenced by ribosomal proteins. Peptides corresponding to the reverse amino acid sequence of the inhibitor peptides are not inhibitory for PT (2, 10) , and the reverse peptides did not alter the nuclease susceptibility of domain IV or V (Figs. 1 and 2) . The anti-PT activity of MVKTD and MSTSKNAD is also eliminated when the peptides are shortened by omitting one amino acid from the N or C terminus (2, 10) . A C-terminal truncation of the 8-mer, designated the 7-mer, was inactive in altering the nuclease susceptibility of the rRNA (Figs. 1 and 2) . Lastly, the anti-PT activity of the 8-mer is abolished by addition of a Lys to the C terminus (2) and this 9-mer did not alter nuclease susceptibility of the rRNA (Figs. 1 and 2) .
Changes resulting from the interaction of inhibitor peptides with rRNA fall into three general classes. Class 1 effects describe the loss or reduction of nuclease cleavage at specific rRNA sites when digestion was performed in the presence of the inhibitor peptides; examples are seen at nt 1993 and 2013 (Fig. 3) . Class 1 effects could result from peptide masking of nuclease susceptible sites, a measure of peptide binding to the rRNA, and/or from peptide-induced changes in the secondary structure of the RNA. Class 2 effects denote new or enhanced sites of Ti cleavage due to the inhibitor peptides; examples are seen at nt 2496 and 2430. Class 2 effects are most directly explained by proposing the peptides introduce subtle changes in the folding of domains V and IV. Additional evidence indicative of peptide-induced changes in rRNA secondary structure was observed in the vicinity of nt 2509 and 2510. The inhibitor peptides partially protected this region from Vi cleavage (Fig. 2) and also caused the appearance of a new Ti sensitive site (Fig. 1) , arguing that the peptides may open a region of the RNA that is normally duplexed.
Examples of a third effect of the inhibitor peptides on rRNA are seen at nt 2037, 2040, 2042, and 2056 (Fig. 1) . In these class 3 effects, a site of secondary-structure-dependent RT termination is eliminated (nt 2037, 2040, and 2042) or enhanced (nt 2056) by the inhibitor peptides (Fig. 1) during Ti cleavage. Class 3 effects were not detected when peptide-rRNA complexes were digested with Vi nuclease (see Fig. 2 ), stggesting that the identified class 3 changes are not directly due to peptide alteration of secondary structure. Rather, we suspect the peptides provoke a site of Ti cleavage elsewhere in the RNA that alters the pattern of folding.
Ti Fig. 1 . The primer was L-EC1. Since the same total quantity of in vivo and in vitro RNA (5 ,ug) was used, the ratio of peptide/23S rRNA is -4000:1 for the in vitro RNA and 6000:1 for the in vivo RNA. Cm and erythromycin (Eryth) were used at 500 ,uM. Neither antibiotic had a detectable effect on the Ti nuclease susceptibility of the rRNA. Nucleotides noted in the figure are those clearly altered in the in vitro rRNA.
of associated ribosomal protein (13) . Conceivably, the binding of the inhibitor peptides to phenol-extracted rRNA could require an associated phenol-resistant ribosomal protein. We therefore examined peptide effects on the Ti nuclease susceptibility in in vitro-transcribed E. coli 23S rRNA (15) . Both the 5-and 8-mer peptides modified the nuclease susceptibility of sites within domain V of the in vitro-transcribed RNA and the control peptides did not (Fig. 4) . The modifications were comparable to those produced by the peptides on rRNA extracted from ribosomes. Differences in nuclease susceptibility between peptide-free in vivo and in vitro rRNA are perhaps due to the conditions under which the RNAs fold: in vitro-prepared rRNA contains unmodified nucleotides (15) and folds independent of bacterial proteins.
Reversing Peptide Effects on rRNA. To test the reversibility of peptide effects on rRNA, E. coli rRNA was incubated with MVKTD or MSTSKNAD for 10 min and a portion was taken to confirm by Ti endonuclease that the peptides had altered the cleavage of domain V. The remainder of the rRNApeptide mixture was precipitated with 95% ice-cold ethanol, resuspended in ribosome buffer containing 0.75 M ammonium acetate, and reprecipitated. The rRNA product was then taken for nuclease probing. RT mapping using L-EC1 as primer demonstrated that removal from the rRNA of the inhibitor peptides restored the Ti nuclease susceptibility seen with rRNA not previously exposed to the peptides (data not shown).
DISCUSSION
Peptide-bond formation during translation and peptide release during translation termination take place in the vicinity of the ribosome's PT center (21, 22) . The PT center is thought to form the most interior portion of an exit tunnel through which nascent peptides pass as they leave the ribosome (23) . The ribosomal P site is adjacent to the PT center and P-site-bound tRNA (the peptidyl-tRNA) is joined at its 3' terminus to the 5-and 8-mer peptides in vivo. Therefore, in vivo the nascent cat-and cmlA-encoded leader peptides extend from their attachment to peptidyl-tRNA into the PT center.
We suggest a mechanism through which the PT inhibitor peptides may bring about translational pausing (Fig. 5 ). In our model, synthesis of the 5-and 8-mer peptides in vivo produces a concomitant alteration of the secondary structure of PT center rRNA within the translating ribosome. The alteration eliminates PT center catalytic activities that include both peptide bond formation (2, 10, 12) and translation termination (11, 22, 24) . The peptide-induced changes in rRNA secondary structure are reversible and may be analogous to allosteric changes in proteins due to small effector molecules (25) .
Dissociation of the nascent inhibitor peptide from the rRNA should permit the paused ribosome to resume translation of the leader. Since resumption of translation drives the inhibitor peptide sequence away from its rRNA target (Fig. 5) , the peptides function as pause signals for translation rather than signals for translation termination.
Peptides as Cis-Regulators of Ribosome Function. cat-and cmlA-encoded leader peptides bind to domains IV and V of E. coli and yeast rRNA (unpublished data). Neither peptide is obviously related to known examples of RNA binding proteins (26, 27) . Therefore, the PT inhibitor peptides represent a specific class of controlling element for RNA. Nascent peptide effects on ribosomes could offer an explanation for other examples of translational control (28) (29) (30) (31) (32) (33) , although it is not yet known whether these examples of putative regulatory peptides are capable of binding to rRNA. While it is likely that ribosome function could be altered by peptide binding to ribosomal protein, the rRNA binding properties of the cat-and cmL4-encoded leader peptides and the apparent rRNA targets of several antibiotics (34) argue that the interaction of small molecules with rRNA may be the preferred mechanism to regulate selected activities within the ribosome.
Origin of the rRNA Binding Peptides. The rRNA binding property of the leader peptides is suggestive of ribosomal proteins, and perhaps sequences specifying the PT inhibitor peptides might have arisen through the modification of the coding regions for ribosomal protein domains that interact with rRNA. The inhibitor peptides are short and amino acid replacements that allow PT inhibition may significantly change the peptides from putative parental proteins. Consequently, computer homology searches to delineate ancestral relationships may be difficult.
Evidence for a Second Function of the Leader Peptides. Induction of cat and cmlA requires Cm, whereas the anti-PT activity of the leader peptides and their binding to rRNA occurs in the absence of the antibiotic. Accordingly, there must be two different steps in translation attenuation regulation: selection of the ribosomal stall site by the nascent peptide and an inducer-dependent effect. cmlA and most cat genes are induced by Cm but not by other ribosomally targeting antibiotics. In contrast, erm genes are regulated by translation attenuation and are induced by erythromycin but not Cm, indicating specificity of the antibiotic inducer (35, 36) . One gene, cat-86, is unusual since it is inducible not only by Cm but also by two non-Cm antibiotics, erythromycin and amicetin (37, 38) . Amicetin, which interacts with the PT center (39, 40) , is of particular interest because selected missense mutations in the cat-86 leader abolish induction by amicetin but have no effect on induction by Cm (41) . Based on these observations, we speculate that the cat-and cmlA-encoded leader peptides may also cooperate with the antibiotic inducer to influence a ribosomal event essential for induction.
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